Effects of GILZ on chemokine production by DCs. MoDCs were treated with control (□) or GILZ (▪) siRNA on day 5, with DEX, IL-10, or medium on days 5 and 7, and with or without CD40L on day 7. Production of CCL3, CCL5, and CXCL8 was determined on day 9. Results (mean ± SEM) are expressed as percentages of the values for controls, treated with control siRNA only (n = 3).